Innospec (IOSP)
(Delayed Data from NSDQ)
$121.65 USD
+1.65 (1.38%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $121.70 +0.05 (0.04%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.65 USD
+1.65 (1.38%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $121.70 +0.05 (0.04%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Zacks News
Innospec (IOSP) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Innospec (IOSP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Innospec (IOSP) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 19.70% and 6.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Air Products and Chemicals (APD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Air Products and Chemicals (APD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innospec (IOSP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is American Vanguard (AVD) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how American Vanguard (AVD) and Innospec (IOSP) have performed compared to their sector so far this year.
Innospec (IOSP) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Innospec (IOSP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Steel Dynamics (STLD) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Steel Dynamics (STLD) and Innospec (IOSP) have performed compared to their sector so far this year.
Are You Looking for a Top Momentum Pick? Why Innospec (IOSP) is a Great Choice
by Zacks Equity Research
Does Innospec (IOSP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Momentum Stocks to Buy for May 25th
by Zacks Equity Research
CIB, IOSP, and EVH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 25, 2022.
Will Innospec (IOSP) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Innospec (IOSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Has Innospec (IOSP) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Innospec (IOSP) and Huntsman (HUN) have performed compared to their sector so far this year.
Innospec (IOSP) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 29.66% and 19.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell (LYB) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of 14.94% and 3.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Innospec (IOSP) Could Beat Earnings Estimates Again
by Zacks Equity Research
Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Innospec (IOSP) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Innospec (IOSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has Allegheny Technologies (ATI) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Allegheny Technologies (ATI) and Innospec (IOSP) have performed compared to their sector so far this year.
Innospec (IOSP) Gets China Approval for Sulfate-Free Surfactants
by Zacks Equity Research
Innospec's (IOSP) technologies, like Iselux, directly deal with increasing long-term consumer demand for clean beauty without compromising product performance.
Innospec (IOSP) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 1.77% and 4.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Innospec (IOSP) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Chemical Stocks Set to Run Higher Despite Supply-Chain Woes
by Anindya Barman
While input cost inflation and supply chain constraints pose headwinds, the chemical industry is expected to benefit from strong demand across major markets. AVNT, MEOH, CC, OLN, IOSP are good options for investment right now.
Why Innospec (IOSP) Might be Well Poised for a Surge
by Zacks Equity Research
Innospec (IOSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Innospec (IOSP) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 32.65% and 4.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Innospec (IOSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innospec (IOSP) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 3.92% and 11.34%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Here is Why Growth Investors Should Buy Innospec (IOSP) Now
by Zacks Equity Research
Innospec (IOSP) could produce exceptional returns because of its solid growth attributes.